论著-头颈部
超声造影、增强CT 扫描及MRI在评估 肝癌介入治疗疗效 中的应用比较
作者:蒋 明1 胡鸿涛2
所属单位:1.河南省安阳市肿瘤医院介入科 (河南 安阳 455000) 2.河南省肿瘤医院放射介入科 (河南 郑州 450008)
PDF摘要
目的 探讨超声造影(Contrastenhanced ultrasound,CEUS)、增强CT扫 描及MRI在评估肝癌介入治疗疗效中的 应用价值。方法 收集2013年3月-2015年 7月我院收治的90例行介入治疗肝癌患 者为研究对象,介入治疗前均行CEUS检 查,介入治疗后分别行CEUS、增强CT扫 描及MRI检查,并以数字减影血管造影 (DSA)为金标准,对各类检查结果进行对 比分析。结果 ①治疗前90例患者行CEUS 检查,共检出120个病灶(动脉期均匀增 强95个,动脉期不均匀强化25个);介入 治疗后1个月,DSA检出阳性、阴性、尚 未确定病灶各76、37、7个;CEUS检出 阳性、阴性、尚未确定病灶各75、40、 5个;增强CT扫描检出阳性、阴性、尚 未确定病灶各58、40、12个;经MRI检出 阳性、阴性、尚未确定病灶各65、45、 10个,CEUS与DSA评价肝癌介入治疗疗 效的一致性较好(Kappa≥0.75),而增 强CT扫描及MRI与DSA检查结果的一致性 较差(Kappa<0.40)。③以DSA检查结果 为金标准,CEUS诊断介入治疗阳性病 灶的灵敏度98.68%(75/76)、总符合率 95.00%(114/120)较增强CT扫描及MRI诊 断效率显著高,假阴性率2.70%(1/37)显 著低(P<0.05)。结论 CEUS在诊断肝癌介 入治疗后阳性病灶灵敏度、与DSA总符合 率较增强CT扫描及MRI更高,而假阴性率 更低,值得推广应用。
Objective To investigate the application value of contrast-enhanced ultrasound (CEUS), enhanced CT scan and MRI in evaluating the efficacy of interventional therapy for hepatocellular carcinoma (HCC). Methods From March 2013 to July 2015, 90 cases with HCC who received interventional therapy in our hospital were enrolled in the study. All patients were examined by CEUS before interventional therapy and they were examined by CEUS, enhanced CT and MRI scan after interventional therapy. With the results of digital subtraction angiography (DSA) as the golden standard, the detection results were compared. Results Before treatment, 90 patients were examined by CEUS, and a total of 120 lesions (homogeneous enhancement in 95 lesions and inhomogeneous enhancement in 25 lesions) were detected. One month after interventional therapy, the numbers of positive, negative and uncertain lesions detected by DSA were 76, 37 and 7,by CEUS were 75, 40 and 5, by enhanced CT scan were 58, 40 and 12, and by MRI were 65, 45 and 10. The consistency of CEUS and DSA in evaluating the efficacy was better (Kappa≥0.75), while the consistency of enhanced CT scan and MRI with the results of DSA was poor (Kappa<0.40). With the results of DSA as the golden standard, the sensitivity and total coincidence rate of CEUS in the diagnosis of positive lesions were 98.68%(75/76) and 95.00% (114/120) which were higher than those of enhanced CT scan and MRI while the false negative rate [2.70% (1/37)] was significantly lower (P<0.05). Conclusion The sensitivity and coincidence rate with DSA of CEUS in the diagnosis of positive lesions after interventional therapy are higher than those of enhanced CT scan and MRI, while the false negative rate is lower.
【关键词】肝癌;介入治疗;超声造 影;增强CT;MRI
【中图分类号】R445.2; R4453; R735.7
【文献标识码】A
【DOI】 10.3969/j.issn.1672- 5131.2017.08.026
前言
肝癌是全球范围内常见多发恶性肿瘤之一,具有病情隐匿、进展 快、易恶化及致死率高等特点,目前早期肝癌患者多以手术切除为主 要治疗手段[1],然而国内肝癌患者大多由乙肝、肝硬化等发展而来, 多数患者身体状况较差,且病灶多位于不同叶段并靠近大血管,加之 较多高龄患者常合并有心脑血管疾病及糖尿病等基础性疾病,多已失 去外科手术切除机会[2]。随近年来经肝动脉灌注导管化疗栓塞术已成 为失去手术切除机会的中晚期肝癌患者的常用治疗手段,然而因介入 治疗属于临床姑息性治疗手段,患者经长期反复的介入治疗仍较难将 全部肿瘤病灶彻底清除,常需经多次、重复治疗,同时需在治疗过程 中对治疗疗效进行多次评估,方可取得理想的介入治疗疗效[3]。近年 来,随着影像学技术讯们发展,借助影像学技术对肝癌患者介入治 疗疗效进行评估的研究早已涉及[4],如应用较多的技术有CEUS、CT及 MRI,但有关何种诊断技术在评估肝癌介入治疗疗效中更具优势尚无定 论,为此笔者于本文展开对照性研究,结果报告如下。
中国CT和MRI杂志
第15卷, 第 8 期
2017年08月
相关文章